Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly
PHASE2Active, not recruitingINTERVENTIONAL
Enrollment
652
Participants
Timeline
Start Date
November 15, 2017
Primary Completion Date
May 3, 2018
Study Completion Date
July 31, 2018
Conditions
Respiratory Tract Infections
Interventions
OTHER
Placebo
oral
DRUG
BEZ235
oral
DRUG
BEZ235 plus everolimus (RAD001)
Oral
Trial Locations (1)
67205
Heartland Research Associates, Wichita
All Listed Sponsors
lead
Restorbio Inc.
INDUSTRY
NCT03373903 - Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly | Biotech Hunter | Biotech Hunter